Drugs that contain Ixabepilone

1. List of Ixempra Kit drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7022330 R-PHARM US LLC Parenteral formulation for epothilone analogs
Jan, 2022

(1 year, 14 days ago)

US6670384 R-PHARM US LLC Methods of administering epothilone analogs for the treatment of cancer
Jan, 2022

(1 year, 14 days ago)

USRE41393 R-PHARM US LLC Treatment of refractory tumors using epothilone derivatives
Feb, 2022

(11 months ago)

US7022330

(Pediatric)

R-PHARM US LLC Parenteral formulation for epothilone analogs
Jul, 2022

(6 months ago)

US6670384

(Pediatric)

R-PHARM US LLC Methods of administering epothilone analogs for the treatment of cancer
Jul, 2022

(6 months ago)

USRE41393

(Pediatric)

R-PHARM US LLC Treatment of refractory tumors using epothilone derivatives
Aug, 2022

(5 months ago)

US7312237 R-PHARM US LLC Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
Aug, 2024

(1 year, 6 months from now)

US7312237

(Pediatric)

R-PHARM US LLC Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
Feb, 2025

(2 years from now)

Market Authorisation Date: 16 October, 2007

Treatment: Method of treating patient comprising mixing first and second vials of product comprising lyophilized ixabepilone to provide an epothilone analog solution, diluting solution with a suitable diluent to prepare intravenous formulation for pt; Method of treating cancer in a patient comprising intravenously administering to the patient ixabepilone diluted in a parenteral diluent; Method of treating cancer, iv admin, lyophilized ixabepilone diluted, every week or 3 weeks; Lyophilized ixabepilone with solvent(dehydrated ethanol) diluted to concentration of 0.1mg/ml to 0.9mg/ml; Method of treating breast cancer by administering ixabepilone; A method of treating a cancer responsible to microtubule stabilization by administering ixabepilone; Use of ixabepilone in combination with capecitabine in treatment of metastasis breast cancer

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of IXEMPRA KIT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in